REGEN-D® 150
Advanced Wound Care with Recombinant Human Epidermal Growth Factor (rhEGF)

REGEN-D® 150 is a cutting-edge, patented recombinant human epidermal growth factor (rhEGF) specifically designed to support efficient wound healing. Exclusively available in India, REGEN-D® 150 is the only product offering this powerful growth factor, providing an innovative solution for faster, more effective wound regeneration. Trusted by healthcare professionals and patients alike, REGEN-D® 150 reassures with its proven efficacy in enhancing the body’s natural healing processes and promoting healthy tissue regeneration.

Indications for REGEN-D® 150

REGEN-D® 150 is indicated for a wide range of wound types, particularly those that require enhanced healing. Some common indications include:

Chronic Wounds

Ideal for conditions like diabetic foot ulcers, pressure ulcers, and venous leg ulcers that are slow to heal.

Acute Wounds

This treatment is effective for surgical wounds, trauma-related injuries, and burns, accelerating recovery and reducing complications.

Skin Grafts and Donor Sites

This facilitates faster skin regeneration, promoting quick recovery after skin grafts and donor site healing.

Post-Surgical Healing

Helps minimize healing time and complications following surgery, promoting faster and healthier tissue regeneration.

Uses of REGEN-D® 150

REGEN-D® 150 plays a crucial role in wound healing by enhancing the body's natural regenerative capabilities. It is suitable for a wide variety of wound types, providing numerous benefits for patients and healthcare providers:

Wound Regeneration

REGEN-D® 150 stimulates the growth of epidermal cells, improving tissue regeneration and promoting faster wound healing.

Faster Healing Process

Speeds up the body’s natural healing response by enhancing cell proliferation and migration, ultimately reducing wound closure time.

Scar Reduction

REGEN-D® 150 minimizes the risk of scarring by facilitating proper tissue formation, improving the cosmetic appearance of healed wounds.

Infection Prevention

Supports the creation of healthy tissue, reducing the risk of infection and complications that may arise during the healing process.

Click Here +91 40 2774 0255

Key Features of REGEN-D® 150

Patented Formula

REGEN-D® 150 is based on patented recombinant technology, ensuring the highest quality and effectiveness in wound care.

Exclusively Available in India

REGEN-D® 150 is the only product in India offering recombinant human epidermal growth factor (rhEGF), setting it apart from other wound care treatments.

Clinically Proven

Backed by clinical research, REGEN-D® 150 has shown consistent results in accelerating wound healing, improving tissue regeneration, and reducing scarring.

Why Choose Us

Have Any Questions? Feel Free To Ask.

Regen-D® 150(recombinant human epidermal growth factor) is a topical gel used for faster healing of Diabetic foot ulcers, Bedsores(Pressure ulcers), Venous leg ulcers. rhEGFs enhances burn wound healing process by reducing the healing time drastically over the natural course, leaving minimal scars with quality healing.

Keep REGEN-D® 150 out of the reach and sight of children. Store REGEN-D® 150 at room temperature (25°C). Do not use REGEN-D® 150 after the expiry date (EXP) which is stated on the package containing the tube. Keep REGEN-D® 60 out of the reach and sight of children. REGEN-D® 60 is stable at room temperature. Do not freeze. Do not use REGEN-D® 60 after the expiry date (EXP) which is stated on the package containing the tube.

REGEN-D® 60 is composed of 60 µg of rhEGF & REGEN-D® 150 is developed from150 µg of rhEGF. The indications for both the products are different. REGEN-D® 60 is indicated for 1st& 2nd degree burns and donor site skin grafts. REGEN-D® 150 is a topical gel used for diabetic foot ulcers, bed sores (pressure ulcers) and venous leg ulcers.

Recombinant human epidermal growth factor (rhEGF) facilitates diverse array of cellular pathways to promote wound healing & tissue recovery. EGF promotes migration, proliferation, cytoprotection, cellular differentiation, collagen synthesis and inhibition of apoptosis. Matrix metalloproteinases (MMPs) are enzymes responsible for collagen & other protein degradation in extracellular matrix (ECM) that is essential for wound re-epithelialization.